X4 Pharmaceuticals (XFOR) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 210.89 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 115.80 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 208.22 Mn |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn | 126.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 126.34 Mn |
| Mar 31, 2026 | 126.29 Mn |
| Dec 31, 2025 | 42.29 Mn |
| Sep 30, 2025 | 43.27 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 201.06 Mn |
| Sep 30, 2024 | 200.87 Mn |
| Jun 30, 2024 | 200.80 Mn |
| Mar 31, 2024 | 199.99 Mn |
| Dec 31, 2023 | 177.81 Mn |
| Sep 30, 2023 | 196.99 Mn |
| Jun 30, 2023 | 168.74 Mn |
| Mar 31, 2023 | 145.97 Mn |
| Dec 31, 2022 | 63.53 Mn |
| Sep 30, 2022 | 83.21 Mn |
| Jun 30, 2022 | 35.44 Mn |
| Mar 31, 2022 | 33.74 Mn |
| Dec 31, 2021 | 25.75 Mn |
| Sep 30, 2021 | 26.61 Mn |